2018
DOI: 10.4103/joah.joah_48_18
|View full text |Cite
|
Sign up to set email alerts
|

Guide lines for management of adult histiocytic disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Recommendations for the management of adult histiocytic disease are sparse. In 2018, our first set of local guidelines were published 1 ; however, owing to the discovery of new molecular data and incorporation of targeted therapies, these guidelines need refinement and updating for the different categories of histiocytic diseases. This document will provide highlights for management of the most commonly encountered histiocytic diseases (Langerhans cell histiocytosis, Erdheim-Chester disease, Rosai-Dorfman disease, and hemophagocytic lymphohistiocytosis).…”
Section: Introductionmentioning
confidence: 99%
“…Recommendations for the management of adult histiocytic disease are sparse. In 2018, our first set of local guidelines were published 1 ; however, owing to the discovery of new molecular data and incorporation of targeted therapies, these guidelines need refinement and updating for the different categories of histiocytic diseases. This document will provide highlights for management of the most commonly encountered histiocytic diseases (Langerhans cell histiocytosis, Erdheim-Chester disease, Rosai-Dorfman disease, and hemophagocytic lymphohistiocytosis).…”
Section: Introductionmentioning
confidence: 99%